Purpose: To prevent recurrence of granular dystrophy by treatment with soft contact lenses. Methods: After penetrating keratoplasty, a soft contact lens was fitted in a 61-year-old woman patient with granular corneal dystrophy. The lens was worn continuously for 53 months. Results: No recurrence was observed. However, the other eye, which was operated on first and not treated with a contact lens, showed severe recurrence of the underlying disease, with granular deposits in the stroma. Conclusions: Fitting of a soft contact lens should be considered in this disease after penetrating keratoplasty.

Sundmacher R, Spelsberg H, Reinhard T: Homologous penetrating central limbokeratoplasty in granular and lattice corneal dystrophy. Cornea 1999;18:664–670.
Severin M, Konen W, Kirchhof B: Granular corneal dystrophy: Treatment with soft contact lenses. Graefes Arch Clin Exp Ophthalmol 1998;236:291–294.
Lyons CJ, McCartney AC, Kirkness CM, Ficker LA, Steele AD, Rice NS: Granular corneal dystrophy: Visual results and pattern of recurrence after lamellar or penetrating keratoplasty. Ophthalmology 1994;101:1812–1817.
Möller HU: Granular corneal dystrophy Groenouw type I: Clinical and genetic aspects. Acta Ophthalmol Suppl 1991;198:1–40.
Konen W, Severin M, Kilp H: Therapy of corneal amiodarone lesions caused by continuous, vital anti-arrhythmia therapy. Fortschr Ophthalmol 1984;81:201–203.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.